Clinic
Medplus Urgent Clinic LLC
Medplus Urgent Clinic LLC was paid $1.04M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoMEDPLUS URGENT CLINIC LLC
TUPELO, MS 38804
TUPELO, MS 38804
33aNPI1881077501assigned 06/30/2015
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.04M
24GClaims64,542
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Mississippi
Rank by total paid#12 of 34
Median peer was paid$441K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,859 | $123K | |
| 2019 | 9,638 | $156K | |
| 2020 | 6,635 | $139K | |
| 2021 | 7,259 | $189K | |
| 2022 | 21,827 | $189K | |
| 2023 | 8,801 | $136K | |
| 2024incomplete | 4,523 | $106K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 9,749 | 7,175 | $409K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 3,338 | 2,611 | $126K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.1% | 3,920 | 2,641 | $94K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.1% | 6,329 | 4,460 | $74K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.9% | 2,425 | 1,753 | $61K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.0% | 1,787 | 1,182 | $52K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.6% | 4,622 | 3,477 | $48K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 4,047 | 1,466 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 8,986 | 6,427 | $22K |
| 99051 | 1.6% | 1,668 | 1,393 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 2,380 | 1,740 | $16K |
| 87428 | 1.5% | 500 | 372 | $16K |
40 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.4% | 1,576 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 2,010 | $14K |
| 87634 | <1% | 601 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 591 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 298 | $9K |
| 87631 | <1% | 159 | $7K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 120 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 87 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 87 | $1K |
| 87420 | <1% | 151 | $1K | |
| 36416 | <1% | 5,086 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 48 | $943.59 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 322 | $797.03 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 600 | $499.98 |
| 99201 | <1% | 27 | $456.22 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,037 | $383.20 |
| 85027 | <1% | 86 | $363.26 | |
| 81003 | <1% | 563 | $323.35 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 39 | $315.90 |
| 36415 | Collection of venous blood by venipuncture | <1% | 165 | $296.42 |
| 87581 | <1% | 12 | $224.52 | |
| 87486 | <1% | 12 | $224.52 | |
| 87529 | <1% | 18 | $189.48 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 24 | $168.75 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 18 | $94.74 |
| 87511 | <1% | 18 | $94.74 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 18 | $94.74 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 12 | $81.19 |
| 87640 | <1% | 38 | $63.16 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 24 | $56.25 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 18 | $31.62 |
| 87653 | <1% | 16 | $31.58 | |
| 87481 | <1% | 16 | $31.58 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 12 | $24.44 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | $15.74 |
| 81025 | <1% | 21 | $6.98 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 503 | $0.00 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 98 | $0.00 |
| 94760 | 0% | 205 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOGAN, SAMANTHA (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Medplus New Albany LLC | New Albany, MS | $47K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.